Literature DB >> 2462670

Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.

A A Jakubowski1, L Souza, F Kelly, K Fain, D Budman, B Clarkson, M A Bonilla, M A Moore, J Gabrilove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2462670     DOI： 10.1056/NEJM198901053200107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Severe neutropenia: a diagnostic approach.

Authors:  H G Munshi; R B Montgomery
Journal:  West J Med       Date:  2000-04

Review 2.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

Review 3.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 4.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

5.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

6.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.

Authors:  T Furukawa; M Takahashi; Y Moriyama; T Koike; I Kurokawa; A Shibata
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

8.  Dictate a discharge summary.

Authors:  T M Penney
Journal:  BMJ       Date:  1989-04-22

9.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

10.  Leukocytoclastic vasculitis complicating granulocyte colony-stimulating factor (G-CSF) induced neutrophil recovery in T gamma-lymphocytosis with severe neutropenia.

Authors:  G Schliesser; H Pralle; J Lohmeyer
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.